go grey glp 1 Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration The Peptide Craze - Ground
Description
While just over 30% of people on Wegovy made it on their medication to the one-year mark in 2021, the year it was approved for weight loss, that figure had nearly doubled by 2024
Social media has also made 'quick fix' solutions like GLP-1s more popular and normal, even for young athletes, Eichner says
10.1210/endo.142.5.8128 127 WeirG
PMID: 35898463
[DOI] [PubMed] [Google Scholar] 33.Salameh TS, Rhea EM, Talbot K, Banks WA
